Results for “”

Entry Author Date Location
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits 01/22/20 New York
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D 01/15/20 New York
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data 01/14/20 National
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline 01/14/20 New York
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy 01/08/20 San Francisco
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies 12/19/19 New York
Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned 12/16/19 New York
Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk 12/13/19 New York
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test 12/10/19 Boston
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule 12/09/19 New York
6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost 12/04/19 New York
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator 12/02/19 Boston
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Biopharma Execs Remain Optimistic Despite Political Headwinds 11/20/19 National
With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite 11/18/19 New York
FDA Again Halts Solid Bio’s Duchenne Gene Therapy Clinical Trial 11/12/19 Boston
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study 11/11/19 National
Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval 11/08/19 New York
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
Page 1 of 87 next page »